BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27374082)

  • 1. Suppression of APC/CCdh1 has subtype specific biological effects in acute myeloid leukemia.
    Ewerth D; Schmidts A; Hein M; Schnerch D; Kvainickas A; Greil C; Duyster J; Engelhardt M; Wäsch R
    Oncotarget; 2016 Jul; 7(30):48220-48230. PubMed ID: 27374082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
    Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
    J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML.
    Bunaciu RP; MacDonald RJ; Jensen HA; Gao F; Wang X; Johnson L; Varner JD; Yen A
    Leuk Lymphoma; 2019 Jul; 60(7):1697-1708. PubMed ID: 30570341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
    PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
    Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
    Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of triciribine as a novel myeloid cell differentiation inducer.
    Suzuki S; Suzuki S; Sato-Nagaoka Y; Ito C; Takahashi S
    PLoS One; 2024; 19(5):e0303428. PubMed ID: 38743735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia.
    Hu L; Liu J; Meng Y; Zheng H; Ding C; Wang H; Charwudzi A; Li M; Li J; Zhai Z; Xiong S
    RNA Biol; 2021 Oct; 18(10):1434-1444. PubMed ID: 33241756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
    Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
    Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
    Riccioni R; Pasquini L; Mariani G; Saulle E; Rossini A; Diverio D; Pelosi E; Vitale A; Chierichini A; Cedrone M; Foà R; Lo Coco F; Peschle C; Testa U
    Haematologica; 2005 May; 90(5):612-24. PubMed ID: 15921376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
    Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-12 inhibits granulocytic differentiation of human NB4 promyelocytic leukemia cells while promoting lipogenesis.
    Xue H; Yang RY; Tai G; Liu FT
    J Leukoc Biol; 2016 Oct; 100(4):657-664. PubMed ID: 27256573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of poly(ADP-ribose) polymerase promotes cell cycle arrest and inhibits neutrophilic differentiation of NB4 acute promyelocytic leukemia cells.
    Bhatia M; Kirkland JB; Meckling-Gill KA
    Cell Growth Differ; 1996 Jan; 7(1):91-100. PubMed ID: 8788037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.
    Abramowitz J; Neuman T; Perlman R; Ben-Yehuda D
    BMC Med Genomics; 2017 Mar; 10(1):18. PubMed ID: 28340577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation.
    Wampfler J; Federzoni EA; Torbett BE; Fey MF; Tschan MP
    Leuk Res; 2016 Feb; 41():96-102. PubMed ID: 26740055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the SUMO Pathway Primes All-
    Baik H; Boulanger M; Hosseini M; Kowalczyk J; Zaghdoudi S; Salem T; Sarry JE; Hicheri Y; Cartron G; Piechaczyk M; Bossis G
    Cancer Res; 2018 May; 78(10):2601-2613. PubMed ID: 29487199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.